Bronchial thermoplasty is a novel, promising  but controversial additional endoscopic asthma treatment procedure.  Essence is reduction of mass of airway smooth muscle which prevent bronchial bronchoconstriction  in a cause of specific and non specific stimulation.

The first study  was undertaken to asses a optimal temperature (75°C)  and their safety and efficacy and achieve of permanent effect of disruption at behavior of ability for full regeneration other structures in bronchial wall.

The clinical trials AIR (Asthma Intervention Trials), RISA (Research in Severe Asthma) and AIR-2 show a little adverse events  such as:. cough, wheezing, shortness of breath and worsening of asthma symptoms during the period immediately  after treatment. The effects of bronchial thermoplasty were evident from 3 month after the procedure as an improvement of quality of life and asthma control, reduction medical visits and days lost from work/school activities and hospitalization.

Bronchial thermoplasty   issues promising and  relatively safe method of asthma treatment, but farthest research are  indispensable for singling out group of asthmatic patients in whom its  application carrying biggest benefit.